Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-55869 | tai-screen-luciferase | 4.752 | 5.69e-25 | 4.24e-04 | 6.99e-04 | 8 | 5 |
int-snw-51382 | tai-screen-luciferase | 7.286 | 3.65e-186 | 4.21e-10 | 1.27e-04 | 13 | 12 |
reg-snw-52 | tai-screen-luciferase | 4.903 | 9.49e-27 | 2.11e-04 | 3.66e-04 | 9 | 6 |
reg-snw-353274 | tai-screen-luciferase | 4.583 | 4.72e-23 | 8.88e-04 | 1.38e-03 | 9 | 4 |
reg-snw-5770 | tai-screen-luciferase | 4.418 | 2.91e-21 | 1.75e-03 | 2.57e-03 | 13 | 7 |
reg-snw-10198 | tai-screen-luciferase | 4.688 | 3.15e-24 | 5.65e-04 | 9.12e-04 | 9 | 5 |
reg-snw-988 | tai-screen-luciferase | 5.672 | 6.20e-37 | 3.20e-06 | 7.14e-06 | 5 | 3 |
reg-snw-6169 | tai-screen-luciferase | 4.851 | 3.99e-26 | 2.70e-04 | 4.60e-04 | 8 | 5 |
reg-snw-4609 | tai-screen-luciferase | 4.325 | 2.79e-20 | 2.52e-03 | 3.58e-03 | 14 | 8 |
reg-snw-84343 | tai-screen-luciferase | 4.236 | 2.24e-19 | 3.52e-03 | 4.83e-03 | 10 | 5 |
reg-snw-9967 | tai-screen-luciferase | 5.027 | 2.86e-28 | 1.15e-04 | 2.08e-04 | 8 | 6 |
reg-snw-57120 | tai-screen-luciferase | 4.450 | 1.33e-21 | 1.54e-03 | 2.29e-03 | 12 | 6 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | Transcription factor | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|---|
ZNF445 | 353274 | 6 | 1.629 | 4.583 | 3 | TF | - | - |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | TF | Yes | Yes |
PAFAH1B1 | 5048 | 18 | -2.583 | 4.586 | 55 | TF | Yes | - |
CTSF | 8722 | 8 | -3.978 | 4.236 | 1 | - | - | Yes |
TNFRSF8 | 943 | 19 | -4.106 | 4.450 | 15 | - | - | - |
CUL4B | 8450 | 21 | -2.809 | 5.269 | 142 | TF | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | TF | - | Yes |
THRAP3 | 9967 | 5 | 2.507 | 5.027 | 22 | - | - | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | - | Yes | Yes |
CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | TF | Yes | Yes |
RB1 | 5925 | 21 | -2.085 | 4.707 | 351 | TF | - | - |
PTPN1 | 5770 | 10 | 2.067 | 4.418 | 1 | - | - | - |
EIF2S2 | 8894 | 31 | -4.320 | 5.672 | 103 | - | Yes | - |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | - | Yes | Yes |
UTP18 | 51096 | 8 | -1.709 | 4.236 | 106 | TF | - | - |
RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | - | Yes | - |
MYC | 4609 | 9 | -1.920 | 4.325 | 77 | TF | - | - |
SIVA1 | 10572 | 5 | -3.759 | 5.027 | 89 | TF | - | Yes |
NME2 | 4831 | 24 | -3.034 | 4.325 | 53 | TF | - | - |
RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | - | Yes | - |
MRPS12 | 6183 | 35 | -5.421 | 5.516 | 341 | TF | Yes | - |
TLK2 | 11011 | 21 | -4.011 | 5.672 | 14 | - | - | - |
GCN1L1 | 10985 | 10 | -2.918 | 4.418 | 43 | TF | - | - |
YBX1 | 4904 | 24 | -3.033 | 5.516 | 296 | TF | - | - |
RAN | 5901 | 38 | -3.809 | 4.325 | 258 | - | Yes | Yes |
MPHOSPH9 | 10198 | 5 | 2.055 | 4.688 | 41 | - | - | - |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | - | Yes |
RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | - | Yes | - |
CDC5L | 988 | 34 | -3.419 | 5.672 | 155 | TF | - | - |
HES4 | 57801 | 19 | -4.153 | 4.450 | 10 | - | - | - |
HPS3 | 84343 | 8 | -1.516 | 4.236 | 41 | - | - | - |
THAP11 | 57215 | 9 | -3.673 | 4.325 | 3 | TF | - | Yes |
GOPC | 57120 | 19 | 1.749 | 4.450 | 68 | - | - | - |
WDR18 | 57418 | 6 | 2.322 | 4.752 | 213 | TF | - | - |
RPL38 | 6169 | 6 | -1.992 | 4.851 | 4 | - | Yes | - |
RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | - | Yes | - |
HDAC8 | 55869 | 6 | 1.228 | 4.752 | 16 | - | - | - |
ODC1 | 4953 | 9 | -2.503 | 4.325 | 12 | - | - | - |
RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | - | Yes | - |
RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | - | Yes | - |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | - | Yes | Yes |
ATP6V1D | 51382 | 30 | -4.131 | 7.286 | 149 | - | - | - |
BRCA2 | 675 | 8 | -1.991 | 4.236 | 111 | TF | - | - |
PSMD3 | 5709 | 22 | -3.935 | 6.408 | 201 | TF | - | Yes |
PSMD8 | 5714 | 15 | -2.916 | 4.418 | 143 | - | - | - |
RPS14 | 6208 | 23 | -4.803 | 7.011 | 204 | - | Yes | - |
RPS19 | 6223 | 21 | -4.701 | 4.752 | 102 | - | Yes | - |
UACA | 55075 | 5 | -2.177 | 4.688 | 76 | TF | - | - |
ACP1 | 52 | 8 | -2.230 | 4.903 | 46 | - | - | - |
RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | - | Yes | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | - | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
TNFRSF8 | 943 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
CDC5L | 988 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
NME2 | 4831 | RPS19 | 6223 | pp | -- | int.Proteinpedia: Mass spectrometry |
MRPS12 | 6183 | THRAP3 | 9967 | pd | > | reg.ITFP.txt: no annot |
ACP1 | 52 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
MYC | 4609 | PSMD3 | 5709 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, KOCH_MYC |
RPS11 | 6205 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
COPA | 1314 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
EIF2S2 | 8894 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
COPA | 1314 | PSMD8 | 5714 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
MRPS12 | 6183 | SIVA1 | 10572 | pd | <> | reg.ITFP.txt: no annot |
CDC5L | 988 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RAN | 5901 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | RPS11 | 6205 | pp | -- | int.Intact: MI:0914(association) |
MYC | 4609 | COPB2 | 9276 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
HDAC8 | 55869 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
RB1 | 5925 | HES4 | 57801 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
ARCN1 | 372 | MYC | 4609 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACP1 | 52 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
YBX1 | 4904 | SERBP1 | 26135 | pd | > | reg.ITFP.txt: no annot |
MYC | 4609 | ODC1 | 4953 | pd | > | reg.TRANSFAC.txt: no annot |
RB1 | 5925 | SERBP1 | 26135 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | RPS4X | 6191 | pp | -- | int.Intact: MI:0914(association) |
YBX1 | 4904 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
CDC5L | 988 | ZNF445 | 353274 | pd | <> | reg.ITFP.txt: no annot |
UTP18 | 51096 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
CKAP5 | 9793 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
SIVA1 | 10572 | WDR18 | 57418 | pd | <> | reg.ITFP.txt: no annot |
MYC | 4609 | YBX1 | 4904 | pd | > | reg.TRANSFAC.txt: no annot |
MYC | 4609 | YBX1 | 4904 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
HSF1 | 3297 | UACA | 55075 | pd | <> | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
MPHOSPH9 | 10198 | UACA | 55075 | pd | < | reg.ITFP.txt: no annot |
MRPS12 | 6183 | WDR18 | 57418 | pd | <> | reg.ITFP.txt: no annot |
CUL4B | 8450 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
PAFAH1B1 | 5048 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
PAFAH1B1 | 5048 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | PTPN1 | 5770 | pd | > | reg.TRANSFAC.txt: no annot |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | GCN1L1 | 10985 | pd | <> | reg.ITFP.txt: no annot |
PSMD3 | 5709 | UTP18 | 51096 | pp | -- | int.I2D: IntAct_Yeast |
MYC | 4609 | RB1 | 5925 | pp | -- | int.I2D: BCI, HPRD, BioGrid; int.Transfac: -; int.Ravasi: -; int.HPRD: in vivo |
MYC | 4609 | RAN | 5901 | pd | > | reg.ITFP.txt: no annot |
RPS13 | 6207 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD3 | 5709 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast, INTEROLOG, Krogan_Core, YeastHigh |
MYC | 4609 | THAP11 | 57215 | pd | < | reg.TRANSFAC.txt: no annot |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | PSMD8 | 5714 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | GCN1L1 | 10985 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD8 | 5714 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
CDC5L | 988 | MPHOSPH9 | 10198 | pd | > | reg.ITFP.txt: no annot |
RPS24 | 6229 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
PSMD8 | 5714 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
MPHOSPH9 | 10198 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
BRCA2 | 675 | CTSF | 8722 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
ACP1 | 52 | CDC5L | 988 | pd | < | reg.ITFP.txt: no annot |
YBX1 | 4904 | RPS24 | 6229 | pp | -- | int.Intact: MI:0914(association) |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
CDC42 | 998 | GOPC | 57120 | pp | -- | int.I2D: BioGrid |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPA | 1314 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
THRAP3 | 9967 | SIVA1 | 10572 | pd | < | reg.ITFP.txt: no annot |
NME2 | 4831 | RPL38 | 6169 | pp | -- | int.Proteinpedia: Mass spectrometry |
MYC | 4609 | NME2 | 4831 | pd | < | reg.TRANSFAC.txt: no annot |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
MYC | 4609 | GCN1L1 | 10985 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid, IntAct, KOCH_MYC, SOURAV_MAPK_HIGH |
CDC5L | 988 | TLK2 | 11011 | pd | > | reg.ITFP.txt: no annot |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
HSF1 | 3297 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
RPS19 | 6223 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
CDC5L | 988 | YBX1 | 4904 | pd | <> | reg.ITFP.txt: no annot |
MRPS12 | 6183 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | GCN1L1 | 10985 | pp | -- | int.I2D: BioGrid |
CDC5L | 988 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
CDC5L | 988 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
CKAP5 | 9793 | MPHOSPH9 | 10198 | pd | > | reg.ITFP.txt: no annot |
BRCA2 | 675 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
CDC42 | 998 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
CDC5L | 988 | RPL38 | 6169 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
CDC5L | 988 | THRAP3 | 9967 | pd | > | reg.ITFP.txt: no annot |
PSMD3 | 5709 | GCN1L1 | 10985 | pd | <> | reg.ITFP.txt: no annot |
PSMD3 | 5709 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
MYC | 4609 | ATP6V1D | 51382 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
COPA | 1314 | PAFAH1B1 | 5048 | pd | <> | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0022627 | cytosolic small ribosomal subunit | 2.66e-15 | 4.34e-11 | 6.207 | 9 | 21 | 39 |
GO:0019058 | viral life cycle | 4.90e-14 | 8.00e-10 | 4.936 | 11 | 25 | 115 |
GO:0019083 | viral transcription | 5.53e-14 | 9.03e-10 | 5.304 | 10 | 22 | 81 |
GO:0006415 | translational termination | 1.16e-13 | 1.90e-09 | 5.201 | 10 | 22 | 87 |
GO:0006413 | translational initiation | 2.11e-13 | 3.44e-09 | 4.748 | 11 | 27 | 131 |
GO:0006414 | translational elongation | 2.32e-13 | 3.78e-09 | 5.105 | 10 | 22 | 93 |
GO:0006412 | translation | 2.41e-13 | 3.93e-09 | 4.146 | 13 | 29 | 235 |
GO:0003735 | structural constituent of ribosome | 4.78e-13 | 7.80e-09 | 4.642 | 11 | 24 | 141 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.30e-13 | 1.19e-08 | 4.944 | 10 | 22 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.86e-12 | 3.03e-08 | 4.811 | 10 | 22 | 114 |
GO:0016071 | mRNA metabolic process | 3.13e-12 | 5.10e-08 | 4.106 | 12 | 29 | 223 |
GO:0016070 | RNA metabolic process | 1.04e-11 | 1.70e-07 | 3.959 | 12 | 29 | 247 |
GO:0044822 | poly(A) RNA binding | 2.28e-11 | 3.72e-07 | 2.570 | 20 | 42 | 1078 |
GO:0016032 | viral process | 5.46e-11 | 8.91e-07 | 3.152 | 15 | 37 | 540 |
GO:0010467 | gene expression | 1.00e-10 | 1.63e-06 | 2.936 | 16 | 36 | 669 |
GO:0016020 | membrane | 4.12e-10 | 6.73e-06 | 2.076 | 23 | 48 | 1746 |
GO:0015935 | small ribosomal subunit | 1.47e-09 | 2.39e-05 | 6.556 | 5 | 9 | 17 |
GO:0005829 | cytosol | 4.80e-09 | 7.84e-05 | 1.699 | 26 | 74 | 2562 |
GO:0005840 | ribosome | 2.73e-08 | 4.45e-04 | 5.024 | 6 | 10 | 59 |
GO:0048205 | COPI coating of Golgi vesicle | 5.92e-08 | 9.66e-04 | 6.622 | 4 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 5.92e-08 | 9.66e-04 | 6.622 | 4 | 6 | 13 |
GO:0070062 | extracellular vesicular exosome | 9.48e-08 | 1.55e-03 | 1.610 | 24 | 51 | 2516 |
GO:0044267 | cellular protein metabolic process | 2.84e-07 | 4.64e-03 | 2.830 | 11 | 29 | 495 |
GO:0000028 | ribosomal small subunit assembly | 9.97e-07 | 1.63e-02 | 7.100 | 3 | 3 | 7 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.02e-06 | 1.66e-02 | 5.678 | 4 | 6 | 25 |
GO:0005925 | focal adhesion | 1.88e-06 | 3.07e-02 | 2.961 | 9 | 23 | 370 |
GO:0005737 | cytoplasm | 2.76e-06 | 4.50e-02 | 1.172 | 28 | 65 | 3976 |
GO:0042274 | ribosomal small subunit biogenesis | 6.20e-06 | 1.01e-01 | 6.322 | 3 | 6 | 12 |
GO:0005730 | nucleolus | 7.54e-06 | 1.23e-01 | 1.692 | 17 | 36 | 1684 |
GO:0042176 | regulation of protein catabolic process | 1.56e-05 | 2.55e-01 | 5.907 | 3 | 4 | 16 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.25e-05 | 6.93e-01 | 5.448 | 3 | 5 | 22 |
GO:0006417 | regulation of translation | 4.40e-05 | 7.18e-01 | 4.345 | 4 | 4 | 63 |
GO:0030490 | maturation of SSU-rRNA | 5.72e-05 | 9.34e-01 | 7.322 | 2 | 2 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 5.72e-05 | 9.34e-01 | 7.322 | 2 | 2 | 4 |
GO:0019843 | rRNA binding | 7.97e-05 | 1.00e+00 | 5.152 | 3 | 4 | 27 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.52e-05 | 1.00e+00 | 7.000 | 2 | 3 | 5 |
GO:0033119 | negative regulation of RNA splicing | 9.52e-05 | 1.00e+00 | 7.000 | 2 | 2 | 5 |
GO:0051219 | phosphoprotein binding | 1.34e-04 | 1.00e+00 | 4.907 | 3 | 4 | 32 |
GO:0045182 | translation regulator activity | 1.42e-04 | 1.00e+00 | 6.737 | 2 | 2 | 6 |
GO:0006924 | activation-induced cell death of T cells | 1.42e-04 | 1.00e+00 | 6.737 | 2 | 2 | 6 |
GO:0007097 | nuclear migration | 1.99e-04 | 1.00e+00 | 6.515 | 2 | 2 | 7 |
GO:0006364 | rRNA processing | 2.27e-04 | 1.00e+00 | 3.737 | 4 | 8 | 96 |
GO:0030521 | androgen receptor signaling pathway | 2.82e-04 | 1.00e+00 | 4.549 | 3 | 3 | 41 |
GO:0030529 | ribonucleoprotein complex | 4.38e-04 | 1.00e+00 | 3.489 | 4 | 8 | 114 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.08e-04 | 1.00e+00 | 4.263 | 3 | 5 | 50 |
GO:0005838 | proteasome regulatory particle | 6.19e-04 | 1.00e+00 | 5.737 | 2 | 3 | 12 |
GO:0005515 | protein binding | 6.27e-04 | 1.00e+00 | 0.695 | 31 | 87 | 6127 |
GO:0005813 | centrosome | 6.29e-04 | 1.00e+00 | 2.502 | 6 | 9 | 339 |
GO:0061024 | membrane organization | 1.11e-03 | 1.00e+00 | 3.132 | 4 | 11 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.22e-03 | 1.00e+00 | 3.093 | 4 | 11 | 150 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.26e-03 | 1.00e+00 | 5.235 | 2 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.26e-03 | 1.00e+00 | 5.235 | 2 | 4 | 17 |
GO:0003697 | single-stranded DNA binding | 1.30e-03 | 1.00e+00 | 3.798 | 3 | 4 | 69 |
GO:0043015 | gamma-tubulin binding | 1.42e-03 | 1.00e+00 | 5.152 | 2 | 2 | 18 |
GO:0000278 | mitotic cell cycle | 1.44e-03 | 1.00e+00 | 2.270 | 6 | 16 | 398 |
GO:0043473 | pigmentation | 1.75e-03 | 1.00e+00 | 5.000 | 2 | 2 | 20 |
GO:0006886 | intracellular protein transport | 2.07e-03 | 1.00e+00 | 2.887 | 4 | 6 | 173 |
GO:0043234 | protein complex | 2.39e-03 | 1.00e+00 | 2.415 | 5 | 9 | 300 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.53e-03 | 1.00e+00 | 4.737 | 2 | 4 | 24 |
GO:0005634 | nucleus | 2.67e-03 | 1.00e+00 | 0.729 | 25 | 66 | 4828 |
GO:0005844 | polysome | 2.74e-03 | 1.00e+00 | 4.678 | 2 | 2 | 25 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.97e-03 | 1.00e+00 | 4.622 | 2 | 2 | 26 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0033176 | proton-transporting V-type ATPase complex | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0033291 | eukaryotic 80S initiation complex | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0004586 | ornithine decarboxylase activity | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0004673 | protein histidine kinase activity | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0034463 | 90S preribosome assembly | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0018106 | peptidyl-histidine phosphorylation | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0033593 | BRCA2-MAGE-D1 complex | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0005175 | CD27 receptor binding | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0033387 | putrescine biosynthetic process from ornithine | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 3.12e-03 | 1.00e+00 | 8.322 | 1 | 1 | 1 |
GO:0019901 | protein kinase binding | 3.15e-03 | 1.00e+00 | 2.322 | 5 | 9 | 320 |
GO:0010332 | response to gamma radiation | 3.68e-03 | 1.00e+00 | 4.464 | 2 | 2 | 29 |
GO:0007093 | mitotic cell cycle checkpoint | 4.20e-03 | 1.00e+00 | 4.368 | 2 | 2 | 31 |
GO:0048471 | perinuclear region of cytoplasm | 5.58e-03 | 1.00e+00 | 1.876 | 6 | 9 | 523 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5.64e-03 | 1.00e+00 | 4.152 | 2 | 2 | 36 |
GO:0007067 | mitotic nuclear division | 5.81e-03 | 1.00e+00 | 2.470 | 4 | 7 | 231 |
GO:0071987 | WD40-repeat domain binding | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0044346 | fibroblast apoptotic process | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 6.24e-03 | 1.00e+00 | 7.322 | 1 | 1 | 2 |
GO:0030218 | erythrocyte differentiation | 6.26e-03 | 1.00e+00 | 4.074 | 2 | 2 | 38 |
GO:0050681 | androgen receptor binding | 6.26e-03 | 1.00e+00 | 4.074 | 2 | 2 | 38 |
GO:0005654 | nucleoplasm | 6.30e-03 | 1.00e+00 | 1.395 | 9 | 26 | 1095 |
GO:0021766 | hippocampus development | 6.59e-03 | 1.00e+00 | 4.037 | 2 | 3 | 39 |
GO:0008134 | transcription factor binding | 7.23e-03 | 1.00e+00 | 2.380 | 4 | 5 | 246 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0043293 | apoptosome | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0048318 | axial mesoderm development | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0032204 | regulation of telomere maintenance | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0097443 | sorting endosome | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0010484 | H3 histone acetyltransferase activity | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0051683 | establishment of Golgi localization | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 2 | 3 |
GO:0031084 | BLOC-2 complex | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 2 | 3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 9.35e-03 | 1.00e+00 | 6.737 | 1 | 1 | 3 |
GO:0008344 | adult locomotory behavior | 9.46e-03 | 1.00e+00 | 3.767 | 2 | 2 | 47 |
GO:0008286 | insulin receptor signaling pathway | 1.03e-02 | 1.00e+00 | 2.737 | 3 | 4 | 144 |
GO:0035690 | cellular response to drug | 1.07e-02 | 1.00e+00 | 3.678 | 2 | 3 | 50 |
GO:0043066 | negative regulation of apoptotic process | 1.11e-02 | 1.00e+00 | 1.886 | 5 | 14 | 433 |
GO:0042981 | regulation of apoptotic process | 1.17e-02 | 1.00e+00 | 2.669 | 3 | 7 | 151 |
GO:0034191 | apolipoprotein A-I receptor binding | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 2 | 4 |
GO:0048478 | replication fork protection | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0090231 | regulation of spindle checkpoint | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 2 | 4 |
GO:0048664 | neuron fate determination | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0045682 | regulation of epidermis development | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0045656 | negative regulation of monocyte differentiation | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0009991 | response to extracellular stimulus | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 4 |
GO:0050679 | positive regulation of epithelial cell proliferation | 1.24e-02 | 1.00e+00 | 3.567 | 2 | 2 | 54 |
GO:0006879 | cellular iron ion homeostasis | 1.37e-02 | 1.00e+00 | 3.489 | 2 | 2 | 57 |
GO:0000502 | proteasome complex | 1.42e-02 | 1.00e+00 | 3.464 | 2 | 4 | 58 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0036336 | dendritic cell migration | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0051782 | negative regulation of cell division | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.55e-02 | 1.00e+00 | 6.000 | 1 | 1 | 5 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.76e-02 | 1.00e+00 | 3.300 | 2 | 6 | 65 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.76e-02 | 1.00e+00 | 1.716 | 5 | 8 | 487 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.76e-02 | 1.00e+00 | 3.300 | 2 | 6 | 65 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.78e-02 | 1.00e+00 | 2.439 | 3 | 5 | 177 |
GO:0005882 | intermediate filament | 1.81e-02 | 1.00e+00 | 3.278 | 2 | 3 | 66 |
GO:0043353 | enucleate erythrocyte differentiation | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0006333 | chromatin assembly or disassembly | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0030141 | secretory granule | 1.86e-02 | 1.00e+00 | 3.256 | 2 | 2 | 67 |
GO:0010485 | H4 histone acetyltransferase activity | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0019215 | intermediate filament binding | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0000974 | Prp19 complex | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0034452 | dynactin binding | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 6 |
GO:0006338 | chromatin remodeling | 1.91e-02 | 1.00e+00 | 3.235 | 2 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.02e-02 | 1.00e+00 | 3.193 | 2 | 8 | 70 |
GO:0006893 | Golgi to plasma membrane transport | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0060136 | embryonic process involved in female pregnancy | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0050658 | RNA transport | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0048027 | mRNA 5'-UTR binding | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0061512 | protein localization to cilium | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0003334 | keratinocyte development | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0070914 | UV-damage excision repair | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 7 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.18e-02 | 1.00e+00 | 3.132 | 2 | 6 | 73 |
GO:0003729 | mRNA binding | 2.18e-02 | 1.00e+00 | 3.132 | 2 | 3 | 73 |
GO:0000785 | chromatin | 2.18e-02 | 1.00e+00 | 3.132 | 2 | 2 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.24e-02 | 1.00e+00 | 3.113 | 2 | 8 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 2.30e-02 | 1.00e+00 | 3.093 | 2 | 2 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.41e-02 | 1.00e+00 | 3.055 | 2 | 6 | 77 |
GO:0031512 | motile primary cilium | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:0003723 | RNA binding | 2.47e-02 | 1.00e+00 | 1.850 | 4 | 10 | 355 |
GO:0006183 | GTP biosynthetic process | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:0007289 | spermatid nucleus differentiation | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:0003993 | acid phosphatase activity | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 8 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.53e-02 | 1.00e+00 | 3.018 | 2 | 8 | 79 |
GO:0010629 | negative regulation of gene expression | 2.59e-02 | 1.00e+00 | 3.000 | 2 | 2 | 80 |
GO:0097284 | hepatocyte apoptotic process | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0006241 | CTP biosynthetic process | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0014075 | response to amine | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0090136 | epithelial cell-cell adhesion | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 2 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 1 | 9 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.84e-02 | 1.00e+00 | 1.360 | 6 | 9 | 748 |
GO:0045618 | positive regulation of keratinocyte differentiation | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 2 | 10 |
GO:0006996 | organelle organization | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.08e-02 | 1.00e+00 | 5.000 | 1 | 1 | 10 |
GO:0008284 | positive regulation of cell proliferation | 3.38e-02 | 1.00e+00 | 1.707 | 4 | 7 | 392 |
GO:0045502 | dynein binding | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0045176 | apical protein localization | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0042551 | neuron maturation | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:2000573 | positive regulation of DNA biosynthetic process | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 2 | 11 |
GO:0051272 | positive regulation of cellular component movement | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0035518 | histone H2A monoubiquitination | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 2 | 11 |
GO:0021819 | layer formation in cerebral cortex | 3.39e-02 | 1.00e+00 | 4.863 | 1 | 1 | 11 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.49e-02 | 1.00e+00 | 2.767 | 2 | 7 | 94 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 3.49e-02 | 1.00e+00 | 2.767 | 2 | 2 | 94 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.62e-02 | 1.00e+00 | 1.442 | 5 | 9 | 589 |
GO:0007051 | spindle organization | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 2 | 12 |
GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific) | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific) | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0048255 | mRNA stabilization | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0047496 | vesicle transport along microtubule | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0097372 | NAD-dependent histone deacetylase activity (H3-K18 specific) | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 12 |
GO:0016568 | chromatin modification | 3.83e-02 | 1.00e+00 | 2.693 | 2 | 2 | 99 |
GO:0003713 | transcription coactivator activity | 3.86e-02 | 1.00e+00 | 2.006 | 3 | 6 | 239 |
GO:0043488 | regulation of mRNA stability | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0046969 | NAD-dependent histone deacetylase activity (H3-K9 specific) | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0001833 | inner cell mass cell proliferation | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0031929 | TOR signaling | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0061647 | histone H3-K9 modification | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0071398 | cellular response to fatty acid | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 2 | 13 |
GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0007062 | sister chromatid cohesion | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 2 | 13 |
GO:0035371 | microtubule plus-end | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0070848 | response to growth factor | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0015671 | oxygen transport | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0006595 | polyamine metabolic process | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0051298 | centrosome duplication | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0006165 | nucleoside diphosphate phosphorylation | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 14 |
GO:0042809 | vitamin D receptor binding | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0030131 | clathrin adaptor complex | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0045445 | myoblast differentiation | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0004550 | nucleoside diphosphate kinase activity | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0048821 | erythrocyte development | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 2 | 15 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 2 | 15 |
GO:0031369 | translation initiation factor binding | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 2 | 15 |
GO:0008585 | female gonad development | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 2 | 15 |
GO:0048854 | brain morphogenesis | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 1 | 15 |
GO:0007405 | neuroblast proliferation | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 16 |
GO:0004407 | histone deacetylase activity | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 16 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 16 |
GO:0019226 | transmission of nerve impulse | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 2 | 16 |
GO:0051276 | chromosome organization | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 16 |
GO:0000209 | protein polyubiquitination | 5.10e-02 | 1.00e+00 | 2.464 | 2 | 7 | 116 |
GO:0005635 | nuclear envelope | 5.10e-02 | 1.00e+00 | 2.464 | 2 | 2 | 116 |
GO:0002548 | monocyte chemotaxis | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0070933 | histone H4 deacetylation | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0075733 | intracellular transport of virus | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 3 | 17 |
GO:0043274 | phospholipase binding | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0007141 | male meiosis I | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0009966 | regulation of signal transduction | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0001556 | oocyte maturation | 5.18e-02 | 1.00e+00 | 4.235 | 1 | 1 | 17 |
GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0030100 | regulation of endocytosis | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0010507 | negative regulation of autophagy | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 1 | 18 |
GO:0006351 | transcription, DNA-templated | 5.50e-02 | 1.00e+00 | 0.862 | 9 | 17 | 1585 |
GO:0006259 | DNA metabolic process | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 19 |
GO:0017134 | fibroblast growth factor binding | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 2 | 19 |
GO:0035145 | exon-exon junction complex | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 19 |
GO:0007050 | cell cycle arrest | 5.90e-02 | 1.00e+00 | 2.345 | 2 | 2 | 126 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 20 |
GO:0030036 | actin cytoskeleton organization | 6.15e-02 | 1.00e+00 | 2.311 | 2 | 3 | 129 |
GO:0046983 | protein dimerization activity | 6.32e-02 | 1.00e+00 | 2.289 | 2 | 3 | 131 |
GO:0007369 | gastrulation | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 1 | 21 |
GO:0042474 | middle ear morphogenesis | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 1 | 21 |
GO:0005689 | U12-type spliceosomal complex | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 2 | 21 |
GO:0070932 | histone H3 deacetylation | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 1 | 21 |
GO:0046847 | filopodium assembly | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 1 | 21 |
GO:0009306 | protein secretion | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 2 | 21 |
GO:0009615 | response to virus | 6.40e-02 | 1.00e+00 | 2.278 | 2 | 4 | 132 |
GO:0033574 | response to testosterone | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 22 |
GO:0007052 | mitotic spindle organization | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 22 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.83e-02 | 1.00e+00 | 2.224 | 2 | 6 | 137 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0071944 | cell periphery | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0001892 | embryonic placenta development | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0051297 | centrosome organization | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 2 | 23 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 23 |
GO:0005761 | mitochondrial ribosome | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 2 | 24 |
GO:0046329 | negative regulation of JNK cascade | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 24 |
GO:0006611 | protein export from nucleus | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 25 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 25 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 25 |
GO:0007569 | cell aging | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 25 |
GO:0046966 | thyroid hormone receptor binding | 7.82e-02 | 1.00e+00 | 3.622 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 7.82e-02 | 1.00e+00 | 3.622 | 1 | 1 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 7.82e-02 | 1.00e+00 | 3.622 | 1 | 2 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 2 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 27 |
GO:0005083 | small GTPase regulator activity | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 27 |
GO:0031424 | keratinization | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 8.11e-02 | 1.00e+00 | 3.567 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 28 |
GO:0043967 | histone H4 acetylation | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 2 | 28 |
GO:0005875 | microtubule associated complex | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 28 |
GO:0007017 | microtubule-based process | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 2 | 28 |
GO:0000118 | histone deacetylase complex | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 28 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 28 |
GO:0003682 | chromatin binding | 8.63e-02 | 1.00e+00 | 1.523 | 3 | 4 | 334 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 8.68e-02 | 1.00e+00 | 3.464 | 1 | 1 | 29 |
GO:0031252 | cell leading edge | 8.68e-02 | 1.00e+00 | 3.464 | 1 | 3 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 8.68e-02 | 1.00e+00 | 3.464 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 8.68e-02 | 1.00e+00 | 3.464 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 8.68e-02 | 1.00e+00 | 3.464 | 1 | 1 | 29 |
GO:0006974 | cellular response to DNA damage stimulus | 8.73e-02 | 1.00e+00 | 2.018 | 2 | 3 | 158 |
GO:0005198 | structural molecule activity | 8.83e-02 | 1.00e+00 | 2.009 | 2 | 5 | 159 |
GO:0010977 | negative regulation of neuron projection development | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 2 | 30 |
GO:0001618 | virus receptor activity | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0051262 | protein tetramerization | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 3 | 30 |
GO:0046875 | ephrin receptor binding | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 2 | 30 |
GO:0070491 | repressing transcription factor binding | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0031647 | regulation of protein stability | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 8.97e-02 | 1.00e+00 | 3.415 | 1 | 2 | 30 |
GO:0045171 | intercellular bridge | 9.25e-02 | 1.00e+00 | 3.368 | 1 | 2 | 31 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 9.25e-02 | 1.00e+00 | 3.368 | 1 | 1 | 31 |
GO:0000398 | mRNA splicing, via spliceosome | 9.40e-02 | 1.00e+00 | 1.956 | 2 | 2 | 165 |
GO:0034644 | cellular response to UV | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 32 |
GO:0033572 | transferrin transport | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 32 |
GO:0070888 | E-box binding | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 32 |
GO:0015992 | proton transport | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 32 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.69e-02 | 1.00e+00 | 1.930 | 2 | 4 | 168 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 33 |
GO:0005158 | insulin receptor binding | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 2 | 33 |
GO:0030971 | receptor tyrosine kinase binding | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 2 | 33 |
GO:0007611 | learning or memory | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 2 | 34 |
GO:0001890 | placenta development | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 2 | 34 |
GO:0051701 | interaction with host | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 1 | 34 |
GO:0071333 | cellular response to glucose stimulus | 1.04e-01 | 1.00e+00 | 3.193 | 1 | 2 | 35 |
GO:0016592 | mediator complex | 1.04e-01 | 1.00e+00 | 3.193 | 1 | 2 | 35 |
GO:0031965 | nuclear membrane | 1.05e-01 | 1.00e+00 | 1.863 | 2 | 2 | 176 |
GO:0007049 | cell cycle | 1.06e-01 | 1.00e+00 | 1.854 | 2 | 4 | 177 |
GO:0034332 | adherens junction organization | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 4 | 36 |
GO:0051402 | neuron apoptotic process | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 36 |
GO:0000228 | nuclear chromosome | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 2 | 36 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 3 | 36 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.08e-01 | 1.00e+00 | 0.980 | 5 | 11 | 811 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 1 | 37 |
GO:0031625 | ubiquitin protein ligase binding | 1.09e-01 | 1.00e+00 | 1.830 | 2 | 4 | 180 |
GO:0097191 | extrinsic apoptotic signaling pathway | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 3 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 1 | 38 |
GO:0090382 | phagosome maturation | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 1 | 38 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.13e-01 | 1.00e+00 | 1.798 | 2 | 5 | 184 |
GO:0051781 | positive regulation of cell division | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 1 | 39 |
GO:0032092 | positive regulation of protein binding | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 1 | 39 |
GO:0050885 | neuromuscular process controlling balance | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 1 | 41 |
GO:0021987 | cerebral cortex development | 1.23e-01 | 1.00e+00 | 2.930 | 1 | 1 | 42 |
GO:0009898 | cytoplasmic side of plasma membrane | 1.23e-01 | 1.00e+00 | 2.930 | 1 | 1 | 42 |
GO:0031532 | actin cytoskeleton reorganization | 1.23e-01 | 1.00e+00 | 2.930 | 1 | 2 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 1.23e-01 | 1.00e+00 | 2.930 | 1 | 1 | 42 |
GO:0003677 | DNA binding | 1.26e-01 | 1.00e+00 | 0.730 | 7 | 14 | 1351 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 1 | 43 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 1 | 43 |
GO:0004402 | histone acetyltransferase activity | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 1 | 43 |
GO:0006355 | regulation of transcription, DNA-templated | 1.28e-01 | 1.00e+00 | 0.798 | 6 | 10 | 1104 |
GO:0007286 | spermatid development | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 44 |
GO:0003712 | transcription cofactor activity | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 44 |
GO:0005871 | kinesin complex | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 44 |
GO:0048146 | positive regulation of fibroblast proliferation | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 2 | 44 |
GO:0043966 | histone H3 acetylation | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 45 |
GO:0009411 | response to UV | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 2 | 45 |
GO:0003924 | GTPase activity | 1.32e-01 | 1.00e+00 | 1.657 | 2 | 6 | 203 |
GO:0051591 | response to cAMP | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 45 |
GO:0044297 | cell body | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 2 | 46 |
GO:0045727 | positive regulation of translation | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 1 | 46 |
GO:0021762 | substantia nigra development | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 2 | 46 |
GO:0001047 | core promoter binding | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 1 | 46 |
GO:0000139 | Golgi membrane | 1.35e-01 | 1.00e+00 | 1.235 | 3 | 7 | 408 |
GO:0001701 | in utero embryonic development | 1.40e-01 | 1.00e+00 | 1.608 | 2 | 2 | 210 |
GO:0019003 | GDP binding | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 48 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 2 | 49 |
GO:0022625 | cytosolic large ribosomal subunit | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 1 | 49 |
GO:0003743 | translation initiation factor activity | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 5 | 49 |
GO:0007030 | Golgi organization | 1.45e-01 | 1.00e+00 | 2.678 | 1 | 3 | 50 |
GO:0000910 | cytokinesis | 1.48e-01 | 1.00e+00 | 2.650 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 1.48e-01 | 1.00e+00 | 2.650 | 1 | 2 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 1.48e-01 | 1.00e+00 | 2.650 | 1 | 1 | 51 |
GO:0004197 | cysteine-type endopeptidase activity | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 2 | 52 |
GO:0016042 | lipid catabolic process | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 2 | 52 |
GO:0006184 | GTP catabolic process | 1.51e-01 | 1.00e+00 | 1.541 | 2 | 6 | 220 |
GO:0006952 | defense response | 1.53e-01 | 1.00e+00 | 2.594 | 1 | 1 | 53 |
GO:0030175 | filopodium | 1.53e-01 | 1.00e+00 | 2.594 | 1 | 2 | 53 |
GO:0019900 | kinase binding | 1.56e-01 | 1.00e+00 | 2.567 | 1 | 3 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 1.56e-01 | 1.00e+00 | 2.567 | 1 | 1 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 2 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 55 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 55 |
GO:0008380 | RNA splicing | 1.64e-01 | 1.00e+00 | 1.464 | 2 | 5 | 232 |
GO:0000724 | double-strand break repair via homologous recombination | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 2 | 57 |
GO:0030097 | hemopoiesis | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 1 | 58 |
GO:0005643 | nuclear pore | 1.69e-01 | 1.00e+00 | 2.439 | 1 | 1 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.69e-01 | 1.00e+00 | 2.439 | 1 | 1 | 59 |
GO:0050728 | negative regulation of inflammatory response | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 2 | 60 |
GO:0010976 | positive regulation of neuron projection development | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 2 | 60 |
GO:0030425 | dendrite | 1.73e-01 | 1.00e+00 | 1.415 | 2 | 3 | 240 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.74e-01 | 1.00e+00 | 2.391 | 1 | 1 | 61 |
GO:0006302 | double-strand break repair | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 2 | 62 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 1 | 62 |
GO:0060337 | type I interferon signaling pathway | 1.79e-01 | 1.00e+00 | 2.345 | 1 | 1 | 63 |
GO:0000776 | kinetochore | 1.79e-01 | 1.00e+00 | 2.345 | 1 | 3 | 63 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.82e-01 | 1.00e+00 | 2.322 | 1 | 1 | 64 |
GO:0007059 | chromosome segregation | 1.82e-01 | 1.00e+00 | 2.322 | 1 | 3 | 64 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 1.82e-01 | 1.00e+00 | 2.322 | 1 | 1 | 64 |
GO:0006469 | negative regulation of protein kinase activity | 1.84e-01 | 1.00e+00 | 2.300 | 1 | 1 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 1.87e-01 | 1.00e+00 | 2.278 | 1 | 3 | 66 |
GO:0043202 | lysosomal lumen | 1.87e-01 | 1.00e+00 | 2.278 | 1 | 1 | 66 |
GO:0043025 | neuronal cell body | 1.88e-01 | 1.00e+00 | 1.333 | 2 | 5 | 254 |
GO:0031295 | T cell costimulation | 1.90e-01 | 1.00e+00 | 2.256 | 1 | 3 | 67 |
GO:0018105 | peptidyl-serine phosphorylation | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 5 | 69 |
GO:0006289 | nucleotide-excision repair | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 1 | 69 |
GO:0050790 | regulation of catalytic activity | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 1 | 69 |
GO:0035264 | multicellular organism growth | 1.97e-01 | 1.00e+00 | 2.193 | 1 | 1 | 70 |
GO:0001503 | ossification | 2.00e-01 | 1.00e+00 | 2.172 | 1 | 2 | 71 |
GO:0010468 | regulation of gene expression | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 1 | 72 |
GO:0000165 | MAPK cascade | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 2 | 72 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.05e-01 | 1.00e+00 | 2.132 | 1 | 2 | 73 |
GO:0002020 | protease binding | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 1 | 74 |
GO:0007265 | Ras protein signal transduction | 2.10e-01 | 1.00e+00 | 2.093 | 1 | 3 | 75 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 2.10e-01 | 1.00e+00 | 2.093 | 1 | 1 | 75 |
GO:0031175 | neuron projection development | 2.10e-01 | 1.00e+00 | 2.093 | 1 | 2 | 75 |
GO:0043065 | positive regulation of apoptotic process | 2.11e-01 | 1.00e+00 | 1.224 | 2 | 6 | 274 |
GO:0007283 | spermatogenesis | 2.13e-01 | 1.00e+00 | 1.213 | 2 | 2 | 276 |
GO:0044325 | ion channel binding | 2.15e-01 | 1.00e+00 | 2.055 | 1 | 3 | 77 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2.15e-01 | 1.00e+00 | 2.055 | 1 | 4 | 77 |
GO:0008584 | male gonad development | 2.15e-01 | 1.00e+00 | 2.055 | 1 | 1 | 77 |
GO:0007229 | integrin-mediated signaling pathway | 2.17e-01 | 1.00e+00 | 2.037 | 1 | 2 | 78 |
GO:0001822 | kidney development | 2.20e-01 | 1.00e+00 | 2.018 | 1 | 2 | 79 |
GO:0071013 | catalytic step 2 spliceosome | 2.20e-01 | 1.00e+00 | 2.018 | 1 | 1 | 79 |
GO:0004725 | protein tyrosine phosphatase activity | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 1 | 80 |
GO:0005814 | centriole | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 1 | 80 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.24e-01 | 1.00e+00 | 1.982 | 1 | 1 | 81 |
GO:0045177 | apical part of cell | 2.27e-01 | 1.00e+00 | 1.964 | 1 | 1 | 82 |
GO:0001726 | ruffle | 2.27e-01 | 1.00e+00 | 1.964 | 1 | 1 | 82 |
GO:0007264 | small GTPase mediated signal transduction | 2.29e-01 | 1.00e+00 | 1.142 | 2 | 7 | 290 |
GO:0005929 | cilium | 2.32e-01 | 1.00e+00 | 1.930 | 1 | 2 | 84 |
GO:0005179 | hormone activity | 2.32e-01 | 1.00e+00 | 1.930 | 1 | 1 | 84 |
GO:0042593 | glucose homeostasis | 2.44e-01 | 1.00e+00 | 1.846 | 1 | 1 | 89 |
GO:0042384 | cilium assembly | 2.46e-01 | 1.00e+00 | 1.830 | 1 | 2 | 90 |
GO:0000922 | spindle pole | 2.48e-01 | 1.00e+00 | 1.814 | 1 | 5 | 91 |
GO:0003690 | double-stranded DNA binding | 2.48e-01 | 1.00e+00 | 1.814 | 1 | 2 | 91 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.51e-01 | 1.00e+00 | 1.798 | 1 | 3 | 92 |
GO:0016605 | PML body | 2.51e-01 | 1.00e+00 | 1.798 | 1 | 2 | 92 |
GO:0042470 | melanosome | 2.51e-01 | 1.00e+00 | 1.798 | 1 | 2 | 92 |
GO:0001649 | osteoblast differentiation | 2.58e-01 | 1.00e+00 | 1.752 | 1 | 3 | 95 |
GO:0001764 | neuron migration | 2.60e-01 | 1.00e+00 | 1.737 | 1 | 2 | 96 |
GO:0030426 | growth cone | 2.62e-01 | 1.00e+00 | 1.722 | 1 | 3 | 97 |
GO:0006112 | energy reserve metabolic process | 2.67e-01 | 1.00e+00 | 1.693 | 1 | 2 | 99 |
GO:0005525 | GTP binding | 2.73e-01 | 1.00e+00 | 0.964 | 2 | 6 | 328 |
GO:0004888 | transmembrane signaling receptor activity | 2.76e-01 | 1.00e+00 | 1.636 | 1 | 1 | 103 |
GO:0043231 | intracellular membrane-bounded organelle | 2.78e-01 | 1.00e+00 | 0.947 | 2 | 3 | 332 |
GO:0014069 | postsynaptic density | 2.83e-01 | 1.00e+00 | 1.594 | 1 | 3 | 106 |
GO:0030496 | midbody | 2.90e-01 | 1.00e+00 | 1.554 | 1 | 4 | 109 |
GO:0005938 | cell cortex | 2.90e-01 | 1.00e+00 | 1.554 | 1 | 1 | 109 |
GO:0007275 | multicellular organismal development | 2.92e-01 | 1.00e+00 | 0.896 | 2 | 2 | 344 |
GO:0031410 | cytoplasmic vesicle | 2.92e-01 | 1.00e+00 | 1.541 | 1 | 1 | 110 |
GO:0005815 | microtubule organizing center | 2.92e-01 | 1.00e+00 | 1.541 | 1 | 4 | 110 |
GO:0007605 | sensory perception of sound | 2.94e-01 | 1.00e+00 | 1.528 | 1 | 1 | 111 |
GO:0015630 | microtubule cytoskeleton | 2.97e-01 | 1.00e+00 | 1.515 | 1 | 4 | 112 |
GO:0005819 | spindle | 3.01e-01 | 1.00e+00 | 1.489 | 1 | 4 | 114 |
GO:0042803 | protein homodimerization activity | 3.03e-01 | 1.00e+00 | 0.638 | 3 | 4 | 617 |
GO:0032496 | response to lipopolysaccharide | 3.18e-01 | 1.00e+00 | 1.391 | 1 | 1 | 122 |
GO:0008285 | negative regulation of cell proliferation | 3.19e-01 | 1.00e+00 | 0.802 | 2 | 3 | 367 |
GO:0001501 | skeletal system development | 3.21e-01 | 1.00e+00 | 1.380 | 1 | 1 | 123 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 3.21e-01 | 1.00e+00 | 1.380 | 1 | 3 | 123 |
GO:0007219 | Notch signaling pathway | 3.25e-01 | 1.00e+00 | 1.356 | 1 | 4 | 125 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.29e-01 | 1.00e+00 | 1.333 | 1 | 3 | 127 |
GO:0008201 | heparin binding | 3.29e-01 | 1.00e+00 | 1.333 | 1 | 1 | 127 |
GO:0005794 | Golgi apparatus | 3.32e-01 | 1.00e+00 | 0.563 | 3 | 8 | 650 |
GO:0030027 | lamellipodium | 3.35e-01 | 1.00e+00 | 1.300 | 1 | 3 | 130 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 3.35e-01 | 1.00e+00 | 1.300 | 1 | 4 | 130 |
GO:0031982 | vesicle | 3.44e-01 | 1.00e+00 | 1.256 | 1 | 2 | 134 |
GO:0005911 | cell-cell junction | 3.60e-01 | 1.00e+00 | 1.172 | 1 | 2 | 142 |
GO:0010628 | positive regulation of gene expression | 3.74e-01 | 1.00e+00 | 1.103 | 1 | 4 | 149 |
GO:0008017 | microtubule binding | 3.76e-01 | 1.00e+00 | 1.093 | 1 | 2 | 150 |
GO:0051260 | protein homooligomerization | 3.76e-01 | 1.00e+00 | 1.093 | 1 | 2 | 150 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.78e-01 | 1.00e+00 | 1.084 | 1 | 2 | 151 |
GO:0044281 | small molecule metabolic process | 3.81e-01 | 1.00e+00 | 0.305 | 5 | 16 | 1295 |
GO:0005769 | early endosome | 3.92e-01 | 1.00e+00 | 1.018 | 1 | 1 | 158 |
GO:0043005 | neuron projection | 3.97e-01 | 1.00e+00 | 0.991 | 1 | 6 | 161 |
GO:0006397 | mRNA processing | 4.12e-01 | 1.00e+00 | 0.921 | 1 | 3 | 169 |
GO:0007420 | brain development | 4.18e-01 | 1.00e+00 | 0.896 | 1 | 3 | 172 |
GO:0030424 | axon | 4.18e-01 | 1.00e+00 | 0.896 | 1 | 4 | 172 |
GO:0016607 | nuclear speck | 4.23e-01 | 1.00e+00 | 0.871 | 1 | 2 | 175 |
GO:0045211 | postsynaptic membrane | 4.27e-01 | 1.00e+00 | 0.854 | 1 | 3 | 177 |
GO:0007596 | blood coagulation | 4.28e-01 | 1.00e+00 | 0.464 | 2 | 5 | 464 |
GO:0006468 | protein phosphorylation | 4.31e-01 | 1.00e+00 | 0.455 | 2 | 6 | 467 |
GO:0019904 | protein domain specific binding | 4.34e-01 | 1.00e+00 | 0.822 | 1 | 3 | 181 |
GO:0005764 | lysosome | 4.36e-01 | 1.00e+00 | 0.814 | 1 | 2 | 182 |
GO:0032403 | protein complex binding | 4.41e-01 | 1.00e+00 | 0.791 | 1 | 2 | 185 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 4.52e-01 | 1.00e+00 | 0.745 | 1 | 5 | 191 |
GO:0042802 | identical protein binding | 4.57e-01 | 1.00e+00 | 0.382 | 2 | 4 | 491 |
GO:0004872 | receptor activity | 4.66e-01 | 1.00e+00 | 0.685 | 1 | 1 | 199 |
GO:0030168 | platelet activation | 4.76e-01 | 1.00e+00 | 0.643 | 1 | 4 | 205 |
GO:0046872 | metal ion binding | 4.88e-01 | 1.00e+00 | 0.127 | 5 | 14 | 1465 |
GO:0005765 | lysosomal membrane | 4.97e-01 | 1.00e+00 | 0.554 | 1 | 2 | 218 |
GO:0019221 | cytokine-mediated signaling pathway | 5.16e-01 | 1.00e+00 | 0.477 | 1 | 5 | 230 |
GO:0006915 | apoptotic process | 5.37e-01 | 1.00e+00 | 0.165 | 2 | 9 | 571 |
GO:0007399 | nervous system development | 5.38e-01 | 1.00e+00 | 0.385 | 1 | 1 | 245 |
GO:0006281 | DNA repair | 5.65e-01 | 1.00e+00 | 0.278 | 1 | 5 | 264 |
GO:0005783 | endoplasmic reticulum | 5.73e-01 | 1.00e+00 | 0.069 | 2 | 6 | 610 |
GO:0000166 | nucleotide binding | 5.76e-01 | 1.00e+00 | 0.235 | 1 | 2 | 272 |
GO:0019899 | enzyme binding | 5.97e-01 | 1.00e+00 | 0.152 | 1 | 5 | 288 |
GO:0042493 | response to drug | 5.97e-01 | 1.00e+00 | 0.152 | 1 | 2 | 288 |
GO:0005856 | cytoskeleton | 6.26e-01 | 1.00e+00 | 0.041 | 1 | 6 | 311 |
GO:0004674 | protein serine/threonine kinase activity | 6.27e-01 | 1.00e+00 | 0.037 | 1 | 6 | 312 |
GO:0035556 | intracellular signal transduction | 6.33e-01 | 1.00e+00 | 0.014 | 1 | 5 | 317 |
GO:0005575 | cellular_component | 6.39e-01 | 1.00e+00 | -0.009 | 1 | 2 | 322 |
GO:0030154 | cell differentiation | 6.42e-01 | 1.00e+00 | -0.022 | 1 | 3 | 325 |
GO:0005739 | mitochondrion | 6.43e-01 | 1.00e+00 | -0.124 | 3 | 10 | 1046 |
GO:0007411 | axon guidance | 6.44e-01 | 1.00e+00 | -0.031 | 1 | 3 | 327 |
GO:0008270 | zinc ion binding | 6.57e-01 | 1.00e+00 | -0.152 | 3 | 7 | 1067 |
GO:0007268 | synaptic transmission | 6.73e-01 | 1.00e+00 | -0.142 | 1 | 1 | 353 |
GO:0030054 | cell junction | 6.76e-01 | 1.00e+00 | -0.154 | 1 | 4 | 356 |
GO:0015031 | protein transport | 6.77e-01 | 1.00e+00 | -0.158 | 1 | 4 | 357 |
GO:0007155 | cell adhesion | 7.04e-01 | 1.00e+00 | -0.263 | 1 | 3 | 384 |
GO:0006508 | proteolysis | 7.27e-01 | 1.00e+00 | -0.357 | 1 | 2 | 410 |
GO:0045892 | negative regulation of transcription, DNA-templated | 7.39e-01 | 1.00e+00 | -0.406 | 1 | 2 | 424 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.40e-01 | 1.00e+00 | -0.409 | 1 | 3 | 425 |
GO:0008150 | biological_process | 7.67e-01 | 1.00e+00 | -0.520 | 1 | 3 | 459 |
GO:0007165 | signal transduction | 8.05e-01 | 1.00e+00 | -0.570 | 2 | 7 | 950 |
GO:0055085 | transmembrane transport | 8.05e-01 | 1.00e+00 | -0.684 | 1 | 3 | 514 |
GO:0005886 | plasma membrane | 8.06e-01 | 1.00e+00 | -0.339 | 7 | 24 | 2834 |
GO:0005524 | ATP binding | 8.07e-01 | 1.00e+00 | -0.496 | 3 | 19 | 1354 |
GO:0003674 | molecular_function | 8.11e-01 | 1.00e+00 | -0.711 | 1 | 1 | 524 |
GO:0045087 | innate immune response | 8.60e-01 | 1.00e+00 | -0.945 | 1 | 11 | 616 |
GO:0005789 | endoplasmic reticulum membrane | 8.69e-01 | 1.00e+00 | -0.991 | 1 | 3 | 636 |
GO:0005615 | extracellular space | 9.62e-01 | 1.00e+00 | -1.658 | 1 | 3 | 1010 |
GO:0005576 | extracellular region | 9.66e-01 | 1.00e+00 | -1.713 | 1 | 4 | 1049 |
GO:0016021 | integral component of membrane | 1.00e+00 | 1.00e+00 | -2.956 | 1 | 4 | 2483 |